Factors associated with COVID-19-related death using OpenSAFELY

Williamson, Elizabeth J., Walker, Alex J., Bhaskaran, Krishnan, Bacon, Seb, Bates, Chris, Morton, Caroline E., Curtis, Helen J., Mehrkar, Amir +22 more·2020·Nature

Cited by (1,015)

Items 401–500 of 1,015

  1. A systematic review and meta-analysis on chloroquine and hydroxychloroquine as monotherapy or combined with azithromycin in COVID-19 treatment
    Ramy Mohamed Ghazy, Abdallah Mostafa Almaghraby, Ramy Shaaban, Ahmed Kamal, Hatem Beshir, Amr Moursi, Ahmed Ramadan, Sarah Hamed N. Taha · 2020 · Scientific Reports
  2. SARS-CoV-2 infection in patients with autoimmune hepatitis
    Thomas Marjot, Gustav Buescher, Marcial Sebode, Eleanor J. Barnes, Alfred Sidney Barritt, Matthew James Armstrong, Luke Baldelli, James M Kennedy, Carolyn Mercer, Ann‐Kathrin Ozga et al. · 2021 · Journal of Hepatology
  3. COVID-19 in immunocompromised populations: implications for prognosis and repurposing of immunotherapies
    Jason D. Goldman, Philip Cameron Robinson, Thomas S. Uldrick, Per T Ljungman · 2021 · Journal for ImmunoTherapy of Cancer
  4. Impact of Age and Sex on COVID-19 Severity Assessed From Radiologic and Clinical Findings
    Yauhen A. Statsenko, Fatmah Al Zahmi, Tetiana Habuza, Taleb Mohamed Almansoori, Darya Smetanina, Gillian Lylian Simiyu, Klaus Gorkom, Miloš Ljubisavljević, Rasha Awawdeh, Hossam Elshekhali et al. · 2022 · Frontiers in Cellular and Infection Microbiology
  5. Recent developments in the immunopathology of COVID ‐19
    Huanping Zhang, Yuanli Sun, Yanfen Wang, Duygu Yazıcı, Dilek Azkur, İsmail Öğülür, Ahmet Kürşat Azkur, Zhaowei Yang, Xiao‐xue Chen, Ai‐Zhi Zhang et al. · 2022 · Allergy
  6. The Wider Impacts of the Coronavirus Pandemic on the NHS*
    Carol Propper, George Stoye, Ben Zaranko · 2020 · Fiscal Studies
  7. Changes in the behavioural determinants of health during the COVID-19 pandemic: gender, socioeconomic and ethnic inequalities in five British cohort studies
    David Bann, Aase Villadsen, Jane Maddock, Alun David Hughes, George B. Ploubidis, Richard J. Silverwood, Praveetha Patalay · 2021 · Journal of Epidemiology & Community Health
  8. American College of Rheumatology Guidance for COVID‐19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 2
    Jeffrey R. Curtis, Sindhu R. Johnson, Donald D. Anthony, Reuben J. Arasaratnam, Lindsey Robert Baden, Anne R. Bass, Cassandra M. Calabrese, Ellen M. Gravallese, Rafael Harpaz, Andrew T. Kroger et al. · 2021 · Arthritis & Rheumatology
  9. Vaccine response following anti-CD20 therapy: a systematic review and meta-analysis of 905 patients
    Abi Vijenthira, Inna Y. Gong, Stephen Betschel, Matthew C. Cheung, Lisa K. Hicks · 2021 · Blood Advances
  10. Risk of severe COVID-19 outcomes associated with immune-mediated inflammatory diseases and immune-modifying therapies: a nationwide cohort study in the OpenSAFELY platform
    Brian MacKenna, Nicholas Alexander Kennedy, Amir Mehrkar, Anna Rowan, James Benjamin Galloway, Julian Matthewman, Kathryn Elizabeth Mansfield, Katie Bechman, Mark Yates, Jeremy Philip Brown et al. · 2022 · The Lancet Rheumatology
  11. Hypoxic and Pharmacological Activation of HIF Inhibits SARS-CoV-2 Infection of Lung Epithelial Cells
    Peter A. C. Wing, Thomas P. Keeley, Xiaodong Alan Zhuang, Young Seok Lee, Maria Prange‐Barczynska, Senko Tsukuda, Sophie B. Morgan, Adam C. Harding, Isobel L.A. Argles, Samvid Kurlekar et al. · 2020 · Cell Reports
  12. Asthma in Adult Patients with COVID-19. Prevalence and Risk of Severe Disease
    Paul Terry, Robert Eric Heidel, Rajiv Dhand · 2021 · American Journal of Respiratory and Critical Care Medicine
  13. What Could Explain the Lower COVID-19 Burden in Africa despite Considerable Circulation of the SARS-CoV-2 Virus?
    Richard G. Wamai, Jason L. Hirsch, Wim V. Damme, David J. Alnwick, Robert C. Bailey, Stephen Hodgins, Uzma Alam, Rosemary Mamka Anyona · 2021 · International Journal of Environmental Research and Public Health
  14. COVID-19 and immune-mediated inflammatory diseases: effect of disease and treatment on COVID-19 outcomes and vaccine responses
    Filippo Fagni, David Simón, Koray Taşçılar, V. Schönau, Michael Sticherling, Markus Friedrich Neurath, Georg Andreas Schett · 2021 · The Lancet Rheumatology
  15. The pandemic predominantly hits poor neighbourhoods? SARS-CoV-2 infections and COVID-19 fatalities in German districts
    Thomas Plümper, Eric Neumayer · 2020 · European Journal of Public Health
  16. As the Pandemic Progresses, How Does Willingness to Vaccinate against COVID-19 Evolve?
    Stephanie Alley, Robert Stanton, Matthew Browne, Quyen Gia To, Saman Khalesi, Susan Lee Williams, Tanya L. Thwaite, Andrew Stuart Fenning, Corneel Vandelanotte · 2021 · International Journal of Environmental Research and Public Health
  17. Resuming professional football (soccer) during the COVID-19 pandemic in a country with high infection rates: a prospective cohort study
    Yorck Olaf Schumacher, Montassar Tabben, Khalid Hassoun, Asmaa Al Marwani, Ibrahim Al Hussein, Peter Valentine Coyle, Ahmed Khellil Abbassi, Hani Taleb Ballan, Abdulaziz Jaham Al-Kuwari, Karim Chamari et al. · 2021 · British Journal of Sports Medicine
  18. Discontinuation versus continuation of renin-angiotensin-system inhibitors in COVID-19 (ACEI-COVID): a prospective, parallel group, randomised, controlled, open-label trial
    Axel Bauer, Michael Schreinlechner, Nikolay Sappler, Theresa Dolejsi, Herbert Tilg, Benedikt A. Aulinger, Günter Weiß, Rosa Bellmann‐Weiler, Christian Adolf, Dominik Georg Friedrich Wolf et al. · 2021 · The Lancet Respiratory Medicine
  19. Deep learning-based lung sound analysis for intelligent stethoscope
    Dong-Min Huang, Jia Huang, Kun Qiao, Nanshan Zhong, Hongzhou Lu, Wenjin Wang · 2023 · Military Medical Research
  20. SARS-CoV-2 infects human adult donor eyes and hESC-derived ocular epithelium
    Anne Zebitz Eriksen, Rasmus Møller, Bar Makovoz, Skyler A. Uhl, Benjamin Robert tenOever, Timothy A. Blenkinsop · 2021 · Cell stem cell
  21. Health-related quality of life issues, including symptoms, in patients with active COVID-19 or post COVID-19; a systematic literature review
    Cecilie Delphin Amdal, Madeline Lee Pe, Ragnhild Sørum Falk, Claire Piccinin, Andrew Bottomley, Juan Ignacio Arrarás, Anne‐Sophie Darlington, Kristin Hofsø, Bernhard Holzner, Nina Marie Høyning Jørgensen et al. · 2021 · Quality of Life Research
  22. Clinical coding of long COVID in English primary care: a federated analysis of 58 million patient records in situ using OpenSAFELY
    The OpenSAFELY Collaborative, Alex J Walker, Brian MacKenna, Peter Inglesby, Christopher T. Rentsch, Helen J Curtis, Caroline E Morton, Jessica Morley, Amir Mehrkar, Seb Bacon et al. · 2021 · British Journal of General Practice
  23. COVID-19 and Diabetes
    Awadhesh Kumar Singh, Kamlesh K. Khunti · 2021 · Annual Review of Medicine
  24. Characterization of humoral and SARS-CoV-2 specific T cell responses in people living with HIV
    Aljawharah Alrubayyi, Ester Gea‐Mallorquí, Emma Touizer, Dan Hameiri‐Bowen, Jakub T. Kopycinski, Bethany G. Charlton, Natasha Fisher-Pearson, Luke Muir, Annachiara Rosa, Chloë Roustan et al. · 2021 · Nature Communications
  25. Sociodemographic, clinical, and immunological factors associated with SARS-CoV-2 diagnosis and severe COVID-19 outcomes in people living with HIV: a retrospective cohort study
    Daniel Kwakye Nomah, Juliana Reyes‐Urueña, Yesika Díaz, Sergio Moreno‐Fornés, Jordi Aceitón, Andreu Bruguera, Rosa Maria Vivanco‐Hidalgo, Josep Maria Llibre, Peré Domingo, Vicenç Falcó et al. · 2021 · The Lancet HIV
  26. Vitamin E and Metabolic Health: Relevance of Interactions with Other Micronutrients
    Sijia Liao, Sylvia Oghogho Omage, Lisa Börmel, Stefan Kluge, M. Schubert, Maria Wallert, Stefan Lorkowski A · 2022 · Antioxidants
  27. BMI and future risk for COVID-19 infection and death across sex, age and ethnicity: Preliminary findings from UK biobank
    Sattar, Naveed, Ho, Frederick K., Gill, Jason MR., Ghouri, Nazim, Gray, Stuart R., Celis-Morales, Carlos A., Katikireddi, S. Vittal, Berry, Colin, Pell, Jill P., McMurray, John JV. et al. · 2020 · Diabetes & Metabolic Syndrome: Clinical Research & Reviews
  28. Preventing infections in children and adults with asplenia
    Grace M. Lee · 2020 · Hematology
  29. Age, Multiple Chronic Conditions, and COVID-19: A Literature Review
    Mayra S. Tisminetzky, Christopher Delude, Tara Hebert, Catherine Carr, Robert Joel Goldberg, Jerry H. Gurwitz · 2020 · The Journals of Gerontology Series A
  30. The aging transcriptome and cellular landscape of the human lung in relation to SARS-CoV-2
    Ryan Dz-Wei Chow, Medha Majety, Sidi Chen · 2021 · Nature Communications
  31. Targeting Androgen Regulation of TMPRSS2 and ACE2 as a Therapeutic Strategy to Combat COVID-19
    Qu Deng, Reyaz ur Rasool, Ronnie M. Russell, Ramakrishnan Natesan, Irfan Ahmed Asangani · 2020 · iScience
  32. LSE–Lancet Commission on the future of the NHS: re-laying the foundations for an equitable and efficient health and care service after COVID-19
    Michael Anderson, Emma Pitchforth, Miqdad Asaria, Carol Brayne, Barbara Casadei, Anita Charlesworth, Angela Coulter, Bryony Dean Franklin, Cam Donaldson, Michael Drummond et al. · 2021 · The Lancet
  33. Risk perception and optimism during the early stages of the COVID-19 pandemic
    Benjamin James Kuper-Smith, Lisa Marie Doppelhofer, Yulia Oganian, Gabriela Rosenblau, Christoph W. Korn · 2021 · Royal Society Open Science
  34. Real-world Effectiveness of the Pfizer-BioNTech BNT162b2 and Oxford-AstraZeneca ChAdOx1-S Vaccines Against SARS-CoV-2 in Solid Organ and Islet Transplant Recipients
    Chris J. Callaghan, Lisa L. Mumford, Rebecca M. K. Curtis, Sarah V Williams, Heather Whitaker, Nick J Andrews, Jamie Lopez Bernal, Ines Ushiro‐Lumb, Gavin J. Pettigrew, Douglas Thorburn et al. · 2022 · Transplantation
  35. Non‐steroidal anti‐inflammatory drugs, prostaglandins, and COVID‐19
    Calum T. Robb, Marie Goepp, Adriano Giorgio Rossi, Chengcan Yao · 2020 · British Journal of Pharmacology
  36. A vulnerability index for COVID-19: spatial analysis at the subnational level in Kenya
    Peter M. Macharia, Noel K. Joseph, Emelda A. Okiro · 2020 · BMJ Global Health
  37. UK COVID-19 lockdown: 100 days of air pollution reduction?
    Jonathan Higham, Cammy Acosta‐Ramírez, Mark Alan Green, Andrew P. Morse · 2020 · Air Quality Atmosphere & Health
  38. Coronavirus Disease 2019–Associated Pulmonary Aspergillosis in Mechanically Ventilated Patients
    Nitipong Permpalung, Teresa Po‐Yu Chiang, Allan B. Massie, Sean X. Zhang, Robin Kimiko Avery, Saman Nematollahi, Darin B. Ostrander, Dorry Lidor Segev, Kieren A. Marr · 2021 · Clinical Infectious Diseases
  39. Obesity and its impact on COVID-19
    Angélica J. M. de Leeuw, Maureen A. M. Oude Luttikhuis, Annemarijn C. Wellen, Christine Müller, Cornelis F. Calkhoven · 2021 · Journal of Molecular Medicine
  40. Associations of BMI with COVID-19 vaccine uptake, vaccine effectiveness, and risk of severe COVID-19 outcomes after vaccination in England: a population-based cohort study
    Carmen Piernas, Martina Patone, Nerys M. Astbury, Min Gao, Aziz Sheikh, Kamlesh K. Khunti, Manu Shankar‐Hari, Sharon Dixon, Carol A. C. Coupland, Paul N Aveyard et al. · 2022 · The Lancet Diabetes & Endocrinology
  41. A public health perspective of aging: do hyper-inflammatory syndromes such as COVID-19, SARS, ARDS, cytokine storm syndrome, and post-ICU syndrome accelerate short- and long-term inflammaging?
    Bektas, Arsun, Schurman, Shepherd H., Franceschi, Claudio, Ferrucci, Luigi · 2020 · Immunity & Ageing
  42. RETRACTED: Based on T-spherical fuzzy environment: A combination of FWZIC and FDOSM for prioritising COVID-19 vaccine dose recipients
    M. A. Alsalem, Hassan A. Alsattar, Ahmed Shihab Albahri, Rawia Tahrir Mohammed, Osamah Shihab Albahri, A.A. Zaidan, Alhamzah Alnoor, Abdullah Hussein Alamoodi, Sarah Qahtan, Bilal Bahaa Zaidan et al. · 2021 · Journal of Infection and Public Health · Retracted
  43. A survey on clinical natural language processing in the United Kingdom from 2007 to 2022
    Wu, Honghan, Wang, Minhong, Wu, Jinge, Francis, Farah, Chang, Yun-Hsuan, Shavick, Alex, Dong, Hang, Poon, Michael T. C., Fitzpatrick, Natalie, Levine, Adam P. et al. · 2022 · npj Digital Medicine
  44. The association between ABO blood group and SARS-CoV-2 infection: A meta-analysis
    Davide Golinelli, Erik Boetto, Elisa Maietti, Maria Pia Fantini · 2020 · PLoS ONE
  45. Variation in SARS-CoV-2 outbreaks across sub-Saharan Africa
    Benjamin L. Rice, Akshaya Vijaya Annapragada, Rachel E. Baker, Marjolein Bruijning, Winfred Dotse‐Gborgbortsi, Keitly Mensah, Ian F. Miller, Nkengafac Villyen Motaze, Antso Hasina Raherinandrasana, Malavika Rajeev et al. · 2021 · Nature Medicine
  46. Ethnicity, household composition and COVID-19 mortality: a national linked data study
    Vahé Nafilyan, Nazrul Islam, Daniel Ayoubkhani, Clare Gilles, Srinivasa Vittal Katikireddi, Rohini Mathur, Annabel Summerfield, Karen Susan Tingay, Miqdad Asaria, Ann Mary John et al. · 2021 · Journal of the Royal Society of Medicine
  47. Ethnic differences in COVID-19 mortality during the first two waves of the Coronavirus Pandemic: a nationwide cohort study of 29 million adults in England
    Vahé Nafilyan, Nazrul Islam, Rohini Mathur, Daniel Ayoubkhani, Amitava Banerjee, Myer Glickman, Ben Humberstone, Ian D. Diamond, Kamlesh K. Khunti · 2021 · European Journal of Epidemiology
  48. Prone positioning of patients with moderate hypoxaemia due to covid-19: multicentre pragmatic randomised trial (COVID-PRONE)
    Michael Fralick, Michael Colacci, Laveena Munshi, Kevin Venus, Lee M. Fidler, Haseena Hussein, Karen Britto, Rob A. Fowler, Bruno R. da Costa, Irfan A. Dhalla et al. · 2022 · BMJ
  49. Machine learning decision tree algorithm role for predicting mortality in critically ill adult COVID-19 patients admitted to the ICU
    Alyaa Elhazmi, Awad Al‐Omari, Hend Sallam, Hani Nabeel Mufti, Ahmed A. Rabie, Mohammed Saeed Saad Alshahrani, Ahmed Mohamed Mady, Adnan Alghamdi, Ali Altalaq, Mohamed H. Azzam et al. · 2022 · Journal of Infection and Public Health
  50. Post-COVID cognitive dysfunction: current status and research recommendations for high risk population
    Meina Quan, Xuechu Wang, Min Gong, Qi Wang, Yan Li, Jianping Jia · 2023 · The Lancet Regional Health - Western Pacific
  51. COVID-19: Implications for Physical Activity, Health Disparities, and Health Equity
    Hasson, Rebecca, Sallis, James F., Coleman, Nailah, Kaushal, Navin, Nocera, Vincenzo G., Keith, NiCole · 2022 · American Journal of Lifestyle Medicine
  52. Obesity as a risk factor for COVID ‐19 mortality in women and men in the UK biobank: Comparisons with influenza/pneumonia and coronary heart disease
    Sanne A. E. Peters, Stephen W MacMahon, Mark Woodward · 2020 · Diabetes Obesity and Metabolism
  53. Risk phenotypes of diabetes and association with COVID-19 severity and death: a living systematic review and meta-analysis
    Sabrina Schlesinger, Manuela Neuenschwander, Alexander Lang, Kalliopi Pafili, Oliver Kuß, Christian Herder, Michael Roden · 2021 · Diabetologia
  54. Impact of body composition on COVID-19 susceptibility and severity: A two-sample multivariable Mendelian randomization study
    Dennis Freuer, Jakob Linseisen, Christa Meisinger · 2021 · Metabolism
  55. Ambient fine particulate matter air pollution and the risk of hospitalization among COVID-19 positive individuals: Cohort study
    Benjamin C. Bowe, Yan Xie, Andrew K. Gibson, Miao Cai, Aaron van Donkelaar, Randall V. Martin, Richard Thomas Burnett, Ziyad Al‐Aly · 2021 · Environment International
  56. Cross-reactive antibodies after SARS-CoV-2 infection and vaccination
    Marloes Grobben, Karlijn van der Straten, Philip J. M. Brouwer, Mitch Brinkkemper, Pauline Maisonnasse, Nathalie Dereuddre‐Bosquet, Brent Appelman, A. H. Ayesha Lavell, Lonneke A. van Vught, Judith A. Burger et al. · 2021 · eLife
  57. Individuals with Down syndrome hospitalized with COVID-19 have more severe disease
    Louise Malle, Cynthia Gao, Chin Hur, Han Truong, Nicole M. Bouvier, Bethany Percha, Xiao‐Fei Kong, Dusan Bogunovic · 2020 · Genetics in Medicine
  58. Childhood asthma outcomes during the COVID‐19 pandemic: Findings from the PeARL multi‐national cohort
    Nikolaos G. Papadopoulos, Alexander G. Mathioudakis, Adnan Čustović, A. Deschildre, Wanda Phipatanakul, Gary Wong, Paraskevi Vicky Xepapadaki, Rola Abou Taam, Ioana Octavia Agache, José Antonio Castro-Rodríguez et al. · 2021 · Allergy
  59. COVID-19: Why does disease severity vary among individuals?
    Saeed Samadizadeh, Maha Masoudi, Mostafa Rastegar, Vahid Salimi, Mahsa Bataghva Shahbaz, Alireza Tahamtan · 2021 · Respiratory Medicine
  60. Nicotine: From Discovery to Biological Effects
    Luigi Sansone, Francesca Milani, Riccardo Fabrizi, Manuel Belli, Mario Cristina, Vincenzo Zagà, Antonio de Iure, Luca Cicconi, Stefano Bonassi, Patrizia Russo · 2023 · International Journal of Molecular Sciences
  61. Asthma and the Coronavirus Disease 2019 Pandemic: A Literature Review
    Mário Morais‐Almeida, Helena Pité, Rita Aguiar, Ignacio Javier Ansotegui, Jean Bousquet · 2020 · International Archives of Allergy and Immunology
  62. Impact of COVID-19 on Immunization Services for Maternal and Infant Vaccines: Results of a Survey Conducted by Imprint—The Immunising Pregnant Women and Infants Network
    Anja Saso, Helen Skirrow, Beate Kampmann · 2020 · Vaccines
  63. The association between socioeconomic status and pandemic influenza: Systematic review and meta-analysis
    Svenn‐Erik Mamelund, Clare Shelley‐Egan, Ole Jørgen Røgeberg · 2021 · PLoS ONE
  64. Physical activity and COVID-19. The basis for an efficient intervention in times of COVID-19 pandemic
    Vicente Javier Clemente‐Suárez, Ana Isabel Beltrán-Velasco, Domingo Jesús Ramos‐Campo, Juan Mielgo‐Ayuso, Pantelis Τ. Nikolaidis, Noelia Belando‐Pedreño, José Francisco Tornero-Aguilera · 2021 · Physiology & Behavior
  65. Outcome of COVID-19 in hospitalised immunocompromised patients: An analysis of the WHO ISARIC CCP-UK prospective cohort study
    Lance C. W. Turtle, Mathew Thorpe, Thomas M Drake, Maaike C. Swets, Carlo Palmieri, Clark D Russell, Antonia Ying Wai Ho, Stephen Aston, Dan Gower Wootton, Alex G Richter et al. · 2023 · PLoS Medicine
  66. Type 2 diabetes mellitus and COVID-19: a narrative review
    Corrao, Salvatore, Pinelli, Karen, Vacca, Martina, Raspanti, Massimo, Argano, Christiano · 2021 · Frontiers in Endocrinology
  67. Changes in COVID-19-related mortality across key demographic and clinical subgroups in England from 2020 to 2022: a retrospective cohort study using the OpenSAFELY platform
    Nab, Linda, Parker, Edward P K, Andrews, Colm D, Hulme, William J, Fisher, Louis, Morley, Jessica, Mehrkar, Amir, MacKenna, Brian, Inglesby, Peter, Morton, Caroline E et al. · 2023 · The Lancet Public Health
  68. Clinical characteristics and risk factors for severe COVID-19 in hospitalized kidney transplant recipients: A multicentric cohort study
    Alexandre Favà, David Cucchiari, Núria Montero, Néstor Toapanta, Francisco Javier Centellas Pérez, Anna Vila-Santandreu, Ana Coloma, María Meneghini, Anna Manonelles, Joana Sellarés et al. · 2020 · American Journal of Transplantation
  69. Use of non-steroidal anti-inflammatory drugs and risk of death from COVID-19: an OpenSAFELY cohort analysis based on two cohorts
    The OpenSAFELY Collaborative, Angel Y. S. Wong, Brian MacKenna, Caroline E Morton, Anna Schultze, Alex J Walker, Krishnan Bhaskaran, Jeremy Philip Brown, Christopher T. Rentsch, Elizabeth Williamson et al. · 2021 · Annals of the Rheumatic Diseases
  70. Effects of the COVID pandemic on pregnancy outcomes
    Maab Elsaddig, Asma A. Khalil · 2021 · Best Practice & Research Clinical Obstetrics & Gynaecology
  71. Cytokine release syndrome in a patient with colorectal cancer after vaccination with BNT162b2
    Lewis Au, Annika Fendler, Scott Thomas Colville Shepherd, Karolina Rzeniewicz, Maddalena Cerrone, Fiona Byrne, Eleanor Carlyle, Kim Edmonds, Lyra Del Rosario, John C Shon et al. · 2021 · Nature Medicine
  72. Hypertension, a Moving Target in COVID-19
    Carmine Savoia, Massimo Volpe, Reinhold Hugo Kreutz · 2021 · Circulation Research
  73. Obesity and mortality in critically ill COVID-19 patients with respiratory failure
    Richard Dana, Aurélie Bannay, Pauline Bourst, Caroline Ziegler, Marie-Reine Losser, Sébastien Gibot, Bruno Lévy, Gérard Audibert, Olivier Ziegler · 2021 · International Journal of Obesity
  74. Metformin use is associated with a reduced risk of mortality in patients with diabetes hospitalised for COVID-19
    Jean‐Daniel Lalau, Abdallah Al‐Salameh, Samy Hadjadj, Thomas Goronflot, Nicolas F. Wiernsperger, Matthieu Pichelin, Ingrid Allix, Coralie Amadou, Olivier Bourron, Thierry Duriez et al. · 2020 · Diabetes & Metabolism
  75. Diabetes and Overweight/Obesity Are Independent, Nonadditive Risk Factors for In-Hospital Severity of COVID-19: An International, Multicenter Retrospective Meta-analysis
    Danielle K. Longmore, Jessica Eden Miller, Siroon Bekkering, Christoph C.S. Saner, Edin Jessica Mifsud, Yanshan Zhu, Richard Saffery, Alistair Nichol, Graham A. Colditz, Kirsty Renfree Short et al. · 2021 · Diabetes Care
  76. Efficacy of BCG Vaccination Against Respiratory Tract Infections in Older Adults During the Coronavirus Disease 2019 Pandemic
    Simone J.C.F.M. Moorlag, Esther Taks, Thijs ten Doesschate, Thomas W. van der Vaart, Axel B. Janssen, Lisa Müller, Philipp Niklas Ostermann, Helga Dijkstra, Heidi Lemmers, Elles R. Simonetti et al. · 2022 · Clinical Infectious Diseases
  77. Prognostic factors for mortality, intensive care unit and hospital admission due to SARS-CoV-2: a systematic review and meta-analysis of cohort studies in Europe
    Constantine Ilias Vardavas, Alexander G. Mathioudakis, Katerina Nikitara, Kimon S. Stamatelopoulos, Georgios A. Georgiopoulos, Revati K. Phalkey, Jo Leonardi‐Bee, Esteve Fernández, Dolors Carnicer-Pont, Jørgen Vestbo et al. · 2022 · European Respiratory Review
  78. When Two Pandemics Meet: Why Is Obesity Associated with Increased COVID-19 Mortality?
    Sam M. Lockhart, Stephen O’Rahilly · 2020 · Med
  79. Covid-19 and Diabetes: A Complex Bidirectional Relationship
    Hermine Muniangi-Muhitu, Elina Akalestou, Victoria Salem, Shivani Misra, Nick S. Oliver, Guy A. Rutter · 2020 · Frontiers in Endocrinology
  80. Impact of COVID-19 national lockdown on asthma exacerbations: interrupted time-series analysis of English primary care data
    Syed Ahmar Shah, Jennifer Kathleen Quint, Bright I. Nwaru, Aziz Sheikh · 2021 · Thorax
  81. Comparison of 30-day case-fatality rate between dialysis and transplant Covid-19 patients: a propensity score matched cohort study
    Tainá Veras de Sandes‐Freitas, Luís Gustavo Modelli de Andrade, Lúcio Requião‐Moura, Marina Pontello Cristelli, Jose Osmar Medina-Pestana, Jocemir Ronaldo Lugon, Ricardo Sesso, For the Brazilian Covid-19 Dialysis Investigators and the Covid-19-KT Brazilian Study Group · 2021 · Journal of Nephrology
  82. The end of the COVID‐19 pandemic
    John P. A. Ioannidis · 2022 · European Journal of Clinical Investigation
  83. Increased expression of ACE2, the SARS-CoV-2 entry receptor, in alveolar and bronchial epithelium of smokers and COPD subjects
    Merel Jacobs, Hannelore P. Van Eeckhoutte, Sara Renata Alex Wijnant, Wim Janssens, Guy Joos, Guy Brusselle, Ken R. Bracke · 2020 · European Respiratory Journal
  84. COPD in the time of COVID-19: an analysis of acute exacerbations and reported behavioural changes in patients with COPD
    Hamish J. C. McAuley, Kate Hadley, Omer Elneima, Christopher Edward Brightling, Rachael A Evans, MICHAEL C. STEINER, Neil J. Greening · 2020 · ERJ Open Research
  85. Influence of socioeconomic deprivation on interventions and outcomes for patients admitted with COVID-19 to critical care units in Scotland: A national cohort study
    Nazir Lone, Joanne Michelle McPeake, Neil I Stewart, Michael C. Blayney, Robert Chan Seem, Lorraine Donaldson, Elaine Glass, Catriona Haddow, Ros Hall, Caroline Saint Martin et al. · 2021 · The Lancet Regional Health - Europe
  86. Lower disease activity but higher risk of severe COVID-19 and herpes zoster in patients with systemic lupus erythematosus with pre-existing autoantibodies neutralising IFN-α
    Alexis Mathian, Paul Breillat, Karim Dorgham, Paul Bastard, Caroline Charre, Raphaël Lhote, Paul Quentric, Quentin Moyon, Alice‐Andrée Mariaggi, Suzanne Mouries-Martin et al. · 2022 · Annals of the Rheumatic Diseases
  87. Acute blood biomarker profiles predict cognitive deficits 6 and 12 months after COVID-19 hospitalization
    Maxime Taquet, Zuzanna Skórniewska, Adam Hampshire, James Duncan Chalmers, Ling‐Pei Ho, Alex Robert Horsley, Michael Marks, Krisnah Poinasamy, Betty Raman, Olivia C. Leavy et al. · 2023 · Nature Medicine
  88. Risk factors associated with post-acute sequelae of SARS-CoV-2: an N3C and NIH RECOVER study
    Elaine Hill, Hemalkumar B. Mehta, Suchetha Sharma, Klint Mane, Sharad Singh, Catherine Z. Xie, Emily Cathey, Johanna Jean Loomba, Seth Russell, Heidi M. Spratt et al. · 2023 · BMC Public Health
  89. Assessment of risk, severity, mortality, glycemic control and antidiabetic agents in patients with diabetes and COVID-19: A narrative review
    Awadhesh Kumar Singh, Kamlesh Khunti · 2020 · Diabetes Research and Clinical Practice
  90. Expression of ACE2 in airways: Implication for COVID‐19 risk and disease management in patients with chronic inflammatory respiratory diseases
    Yin Yao, Hai Wang, Zheng Liu · 2020 · Clinical & Experimental Allergy
  91. Age-related susceptibility to coronavirus infections: role of impaired and dysregulated host immunity
    Rudragouda Channappanavar, Stanley M. Perlman · 2020 · Journal of Clinical Investigation
  92. IMPact of the COVID-19 epidemic on the moRTAlity of kidney transplant recipients and candidates in a French Nationwide registry sTudy (IMPORTANT)
    Camille Legeai, Camille Legeai, Dany Anglicheau, Lionel Couzi, Gilles Blancho, Marc Hazzan, Myriam Pastural, Émilie Savoye, Florian Bayer, Emmanuel Morélon et al. · 2020 · Kidney International
  93. COVID-19 in patients with systemic lupus erythematosus: lessons learned from the inflammatory disease
    Ruth Fernandez‐Ruiz, Jacqueline L Paredes, Timothy B. Niewold · 2020 · Translational research
  94. Increased COVID-19 infections in women with polycystic ovary syndrome: a population-based study
    Anuradhaa Subramanian, Astha Anand, Nicola Jaime Adderley, Kelvin Okoth, Konstantinos A. Toulis, Krishna Margadhamane Gokhale, Christopher A. R. Sainsbury, Michael O’Reilly, Wiebke Arlt, Krishnarajah Nirantharakumar · 2021 · European Journal of Endocrinology
  95. Diabetes and COVID-19: Population Impact 18 Months Into the Pandemic
    Edward W. Gregg, Marisa K. Sophiea, Misghina Weldegiorgis · 2021 · Diabetes Care
  96. Severity of Severe Acute Respiratory System Coronavirus 2 (SARS-CoV-2) Alpha Variant (B.1.1.7) in England
    Daniel J. Grint, Kevin Wing, Catherine F. Houlihan, Hamish P. Gibbs, Stephen J. W. Evans, Elizabeth Williamson, Helen I McDonald, Krishnan Bhaskaran, David Evans, Alex J Walker et al. · 2021 · Clinical Infectious Diseases
  97. Association of Race and Ethnicity With COVID‐19 Outcomes in Rheumatic Disease: Data From the COVID‐19 Global Rheumatology Alliance Physician Registry
    Milena A. Gianfrancesco, Liza Leykina, Zara Izadi, Tiffany Taylor, Jeffrey A. Sparks, Carly Harrison, Laura S. Trupin, Stephanie Rush, Gabriela Schmajuk, Patricia Katz et al. · 2020 · Arthritis & Rheumatology
  98. Association Between Race and COVID-19 Outcomes Among 2.6 Million Children in England
    Defne Saatci, Tom A. Ranger, César Garriga, Ash Kieran Clift, Francesco Zaccardi, Pui San Tan, Martina Patone, Carol A. C. Coupland, Anthony Harnden, Simon J. Griffin et al. · 2021 · Archives of Pediatrics and Adolescent Medicine
  99. Reduced humoral immune response after BNT162b2 coronavirus disease 2019 messenger RNA vaccination in cancer patients under antineoplastic treatment
    Marc Peeters, Lise Verbruggen, Laure-Anne Marie Nicole Teuwen, Greetje Vanhoutte, Sara Vande Kerckhove, Bart Peeters, Silke Raats, Isolde Van der Massen, Sven De Keersmaecker, Yana Debie et al. · 2021 · ESMO Open
  100. COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study
    Thomas Chatzikonstantinou, Anargyros Kapetanakis, Lydia Scarfò, Georgios Karakatsoulis, David John Allsup, Alejandro Alonso Cabrero, Martin Andres, Darko A. Antic, Mónica Baile, Panagiotis Baliakas et al. · 2021 · Leukemia